What is the level of liabilities of CSL this year?
CSL has a debt balance of 20.07 B USD this year.
CSL Liabilities 2025
CSL Liabilities
20.07 B USD
Ticker
CSL.AX
ISIN
AU000000CSL8
WKN
890952
In 2025, CSL's total liabilities amounted to 20.07 B USD, a -1.85% difference from the 20.45 B USD total liabilities in the previous year.
CSL Aktienanalyse
What does CSL do?
CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing CSL's Liabilities
CSL's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating CSL's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing CSL's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
CSL's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in CSL’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about CSL stock
What were the liabilities of CSL compared to the previous year?
The liabilities of CSL have increased by -1.85% dropped compared to the previous year.
What are the consequences of high debt for investors of CSL?
High liabilities can pose a risk for investors of CSL, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in CSL?
Low liabilities mean that CSL has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of CSL affect the company?
An increase in liabilities of CSL can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of CSL affect the company?
A decrease in the liabilities of CSL can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of CSL?
Some factors that can influence the liabilities of CSL include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of CSL so important for investors?
The liabilities of CSL are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can CSL take to modify the liabilities?
To change its liabilities, CSL can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does CSL pay?
Over the past 12 months, CSL paid a dividend of 4.25 USD . This corresponds to a dividend yield of about 3.24 %. For the coming 12 months, CSL is expected to pay a dividend of 4.9 USD.
What is the dividend yield of CSL?
The current dividend yield of CSL is 3.24 %.
When does CSL pay dividends?
CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of CSL?
CSL paid dividends every year for the past 26 years.
What is the dividend of CSL?
For the upcoming 12 months, dividends amounting to 4.9 USD are expected. This corresponds to a dividend yield of 3.74 %.
In which sector is CSL located?
CSL is assigned to the 'Health' sector.
Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CSL from 10/3/2025 amounting to 2.451 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2025.
When did CSL pay the last dividend?
The last dividend was paid out on 10/3/2025.
What was the dividend of CSL in the year 2024?
In the year 2024, CSL distributed 1.799 USD as dividends.
In which currency does CSL pay out the dividend?
The dividends of CSL are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The CSL stock can be added to a savings plan with the following providers: Consorsbank
Andere Kennzahlen von CSL
Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
